Emi1-mediated M-phase arrest in Xenopus eggs is distinct from cytostatic factor arrest

Keita Ohsumi1, Ayako Koyanagi, Tomomi M Yamamoto

  • 1Laboratory of Cell and Developmental Biology, Graduate School of Bioscience, Tokyo Institute of Technology, Nagatsuta, Midoriku, Yokohama 226-8501, Japan. kohsumi@bio.titech.ac.jp

Insights

Early mitotic inhibitor Emi1 is not a component of cytostatic factor (CSF). Studies show Emi1 is absent in mature eggs and destroyed during meiosis II arrest, indicating it does not regulate cyclin B destruction for this process.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • Oocytes arrest at meiosis II (meta-II) via cytostatic factor (CSF) to prevent parthenogenesis.
  • CSF maintains cyclin B-Cdc2 activity by preventing cyclin B destruction, involving the Mos-MAPK and Ca-CaMKII pathways.
  • The precise regulation of cyclin B destruction in CSF arrest remains unclear.

Purpose of the Study:

  • To investigate the role of early mitotic inhibitor Emi1 as a potential component of CSF.
  • To determine if Emi1 regulates cyclin B destruction during meiosis II arrest.

Main Methods:

  • Analysis of Emi1 expression in unfertilized Xenopus eggs.
  • Experimentation with exogenous Emi1 in meta-II and mitotic metaphase.
  • Assessment of Emi1's effect on meiotic progression and M phase arrest.

Main Results:

  • Emi1 is absent in unfertilized mature Xenopus eggs.
  • Exogenous Emi1 is degraded in both meta-II and mitotic metaphase.
  • Emi1 expression hinders meiotic progression; Emi1-mediated arrest is independent of MAPK and Ca.
  • Emi1 does not appear to be a component of CSF.

Conclusions:

  • Emi1 is unlikely to be a component of cytostatic factor (CSF).
  • The mechanism of cyclin B destruction regulation in meta-II arrest requires further investigation.
  • Emi1's role in cell cycle regulation differs from its proposed function in CSF.